Cargando…

Complete response after autologous stem cell transplant in multiple myeloma

We evaluated long-term outcome of patients achieving complete response (CR) after autologous stem cell transplantation (ASCT) for multiple myeloma. Between April 1990 and June 2012 191 patients underwent ASCT. The median age was 53 years (range, 26–68 years), 135 were men. Pretransplant, patients re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Lalit, Iqbal, Nida, Mookerjee, Anjali, Verma, Rakesh Kumar, Sharma, Om D, Batra, Atul, Pramanik, Raja, Gupta, Ritu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303161/ https://www.ncbi.nlm.nih.gov/pubmed/24777883 http://dx.doi.org/10.1002/cam4.257

Ejemplares similares

High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: Predictors of long-term outcome
por: Kumar, Lalit, et al.
Publicado: (2019)

Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple Myeloma
por: Kumar, Lalit, et al.
Publicado: (2019)

Long-Term Outcomes and Safety Trends of Autologous Stem-Cell Transplantation in Non-Hodgkin Lymphoma: A Report From A Tertiary Care Center in India
por: Kumar, Sudhir, et al.
Publicado: (2022)

Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma
por: Andronesi, Andreea G., et al.
Publicado: (2019)

Does Ethnicity Matter in Multiple Myeloma Risk Prediction in the Era of Genomics and Novel Agents? Evidence From Real-World Data
por: Farswan, Akanksha, et al.
Publicado: (2021)

AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenario
por: Farswan, Akanksha, et al.
Publicado: (2021)

Involvement of DPP3 in modulating oncological features and oxidative stress response in esophageal squamous cell carcinoma
por: Arora, Mohit, et al.
Publicado: (2023)

Sequential, Autologous Hematopoietic Stem Cell Transplant Followed by Renal Transplant in Multiple Myeloma
por: Bhowmik, D., et al.
Publicado: (2017)

Staging System to Predict the Risk of Relapse in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
por: Goswami, Chitrita, et al.
Publicado: (2019)

Isolated central nervous system relapse of multiple myeloma post autologous stem cell transplant- A rare presentation
por: Mittal, Abhenil, et al.
Publicado: (2020)

Engraftment Syndrome: A Retrospective Analysis of the Experience at a Tertiary Care Institute
por: Pramanik, Raja, et al.
Publicado: (2019)

Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
por: Gu, Jingli, et al.
Publicado: (2021)

Genome-wide identification of potential biomarkers in multiple myeloma using meta-analysis of mRNA and miRNA expression data
por: Katiyar, Amit, et al.
Publicado: (2021)

Racial and ethnic differences in the utilization of autologous transplantation for lymphoma in the United States
por: Vaughn, John L., et al.
Publicado: (2021)

Analysis of long‐term survival in multiple myeloma after first‐line autologous stem cell transplantation: impact of clinical risk factors and sustained response
por: Lehners, Nicola, et al.
Publicado: (2017)

Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China
por: Gao, Wen, et al.
Publicado: (2020)

Programmed environmental illumination during autologous stem cell transplantation hospitalization for the treatment of multiple myeloma reduces severity of depression: A preliminary randomized controlled trial
por: Valdimarsdottir, Heiðdís B., et al.
Publicado: (2018)

Comparison of BEAM vs. LEAM regimen in autologous transplant for lymphoma at AIIMS
por: Sharma, Atul, et al.
Publicado: (2013)

Preimmunization of donor lymphocytes enhances antitumor immunity of autologous hematopoietic stem cell transplantation
por: Suzuki, Koji, et al.
Publicado: (2013)

Autologous transplant for myeloma: when the old meets the new
por: Gay, Francesca, et al.
Publicado: (2017)

Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
por: Minnie, Simone A., et al.
Publicado: (2021)

Chronic lymphocytic leukemia with deletion 17p: An Indian scenario
por: Gogia, Ajay, et al.
Publicado: (2019)

Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma
por: Paquin, Ashley, et al.
Publicado: (2020)

Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study)
por: Santhosh, Akhil, et al.
Publicado: (2022)

Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation
por: Sharma, Atul, et al.
Publicado: (2017)

Current status of autologous stem cell transplantation for multiple myeloma
por: Al Hamed, Rama, et al.
Publicado: (2019)

Serum galactomannan assay for diagnosis of probable invasive Aspergillosis in acute leukemia and hematopoietic stem cell transplantation
por: Ghosh, Indranil, et al.
Publicado: (2013)

The Impact of Re-induction Prior to Salvage Autologous Stem Cell Transplantation in Multiple Myeloma
por: Miller, Kevin C., et al.
Publicado: (2019)

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
por: Sidiqi, M. Hasib, et al.
Publicado: (2018)

Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma
por: Bergantim, Rui, et al.
Publicado: (2012)

Update on Salvage Options in Relapsed/Refractory Hodgkin Lymphoma after Autotransplant
por: Iqbal, Nida, et al.
Publicado: (2014)

Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma
por: Kansagra, Ankit, et al.
Publicado: (2022)

Portrait of an autologous cancer vaccine: Then and now
por: Berd, David
Publicado: (2023)

Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma
por: Bao, Alicia, et al.
Publicado: (2023)

Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma without Cryopreservation
por: Al-Anazi, Khalid Ahmed
Publicado: (2012)

Update on the Role of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
por: Tosi, P., et al.
Publicado: (2012)

Outcomes of autologous transplantation for multiple myeloma according to different induction regimens
por: de Queiroz Crusoe, Edvan, et al.
Publicado: (2014)

Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
por: Al-Mansour, Zeina, et al.
Publicado: (2014)

Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
por: Yarlagadda, Lakshmi, et al.
Publicado: (2021)

Interrupted Identities: Autologous Stem Cell Transplant in Patients With Multiple Myeloma
por: Halpin, Sean N, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kv532pto44p7jqdg6ni93vucne